Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT03946865 Enrolling by invitation - Cancer Clinical Trials

Reiki Therapy - an Intervention in Hematology/Oncology Cancer Patients Hospitalized

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Researchers are trying to determine if offering and providing reiki therapy in hospitalized hematology/oncology cancer subjects has any effects on symptoms and feeling during the subjects hospital stay.

NCT ID: NCT03934866 Enrolling by invitation - Cancer Clinical Trials

The SUMMIT Study: A Cancer Screening Study

SUMMIT
Start date: April 8, 2019
Phase:
Study type: Observational

The SUMMIT Study will enrol 50,000 participants in order to investigate how cancer screening can be improved and delivered. The SUMMIT Study has two main aims: the first is to clinically validate a blood test for detecting multiple cancers at an early stage. The second is to examine the feasibility of delivering a low-dose CT (LDCT) screening service for lung cancer to a high-risk population in north and east London.

NCT ID: NCT03879096 Enrolling by invitation - Cancer Clinical Trials

Clinical and Functional Variables in Oncology

Oncolab
Start date: May 1, 2016
Phase: N/A
Study type: Interventional

The aim is to analyse the effect of a Therapeutic Exercise and Education programme in several clinical and functional outcomes in cancer patient and survivors

NCT ID: NCT03681873 Enrolling by invitation - Cancer Clinical Trials

Validation of Low Dose CT for Diagnosis of Lung Nodules

Start date: November 30, 2018
Phase: N/A
Study type: Interventional

The investigators have developed an extremely low dose computed tomography (CT) protocol that on preliminary testing has an effective dose in the range of two chest radiographs. The investigators plan to test this exam in patients with known or suspected cancer undergoing clinically indicated chest CT.

NCT ID: NCT03557762 Enrolling by invitation - Cancer Clinical Trials

The SEAMLESS Study: Smartphone App-based Mindfulness for Cancer Survivors

Start date: January 25, 2019
Phase: N/A
Study type: Interventional

Smartphone app-based health interventions are an innovative way to deliver psychosocial cancer-care. In the SEAMLESS study, the investigators aim to evaluate a 4 week smartphone app-based mind-body intervention (MBI) in cancer survivors post-treatment. This is a randomized controlled trial, with a waitlist control group. Participants will be assigned to either receive the intervention immediately after enrollment or will need to wait for 3 months to receive the intervention.

NCT ID: NCT03543358 Enrolling by invitation - Cancer Clinical Trials

A Long-Term Study of Rovalpituzumab Tesirine

Start date: September 10, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this long-term, extension study is to provide ongoing safety and efficacy follow-up of subjects who participated in a rovalpituzumab tesirine study that has completed the primary analysis and that is closing.

NCT ID: NCT03469271 Enrolling by invitation - Cancer Clinical Trials

Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients

Start date: May 25, 2018
Phase: Phase 4
Study type: Interventional

This research is intended to begin to explore the impact of inspiratory muscle resistance exercise and/or 1,25(OH)2D3 for improving respiratory muscle strength in cancer patients (subjects).

NCT ID: NCT03446092 Enrolling by invitation - Cancer Clinical Trials

Mindfulness for People With Incurable Cancer

Start date: November 19, 2018
Phase: N/A
Study type: Interventional

The study will investigate whether a mindfulness course can help people with incurable cancer who are seen by oncologists in a particular National Health Service Hospital Trust in the United Kingdom.

NCT ID: NCT03436290 Enrolling by invitation - Cancer Clinical Trials

Surgery for Cancer With Option of Palliative Care Expert

SCOPE
Start date: March 1, 2018
Phase: N/A
Study type: Interventional

Frequently people diagnosed with cancer experience physical and emotional symptoms during the course of their disease. These symptoms can be very distressing to both the patient and the family members. The study doctor wants to know if the introduction of a team of clinicians that specialize in the lessening of many of these distressing symptoms may improve your overall care. This team of clinicians is called the palliative care team and they focus on ways to improve your pain and other symptom management (i.e. shortness of breath, fatigue, anxiety, etc.) and to assist you and your family in coping with the emotional, social, and spiritual issues associated with your diagnosis. The team consists of physicians, advanced practice nurses, case managers, and nurses who have been specially trained in the care of patients facing serious illness. This research study is being done because although many people with cancer receive palliative care late in the course of their illness, the study team thinks palliative care may be more useful when it is started earlier and in this case before surgery. The main purpose of this study is to compare two types of care -usual surgery and cancer care and usual surgery and cancer care with comprehensive palliative care services to see which is better for improving the experience of patients and families with cancer.

NCT ID: NCT03394859 Enrolling by invitation - Diabetes Clinical Trials

Electronic Medical Records and Genomics (eMERGE) Phase III

eMERGE
Start date: September 1, 2015
Phase:
Study type: Observational

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clinically relevant, actionable genes. The genetic results will be returned to participants and outcomes tracked through the electronic health records.